Zhi-Yi Zhang

Zhi-Yi Zhang, PhD, is a seasoned professional in clinical pharmacology and drug metabolism, currently serving as Sr. Director of ADME-PK/Clinical Pharmacology at Dyne Therapeutics since January 2021. Previously, Zhi-Yi held key leadership roles including Sr. Director of Clinical Pharmacology and Modeling Sciences at GSK, and Sr. Director of Clinical Pharmacology & Drug Disposition at TESARO, contributing significantly to the development of oncology therapeutics. Zhi-Yi's extensive experience spans various companies, including consulting roles at Amgen and Biogen Idec, team leadership at CombinatoRx, and drug metabolism research at Eisai Research Institute. Zhi-Yi completed postdoctoral training at MIT and earned a PhD in Environmental Health & Toxicology from the University at Albany, SUNY, alongside other advanced degrees in environmental science and medicine.